|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/30 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C12P 21/08 | (2006.01) | ||
| A61K 35/00 | (2006.01) |
| (11) | Number of the document | 2648752 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11847198.6 |
| Date of filing the European patent application | 2011-12-06 | |
| (97) | Date of publication of the European application | 2013-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-15 |
| (46) | Date of publication of the claims translation | 2017-04-10 |
| (86) | Number | PCT/US2011/063612 |
| Date | 2011-12-06 |
| (87) | Number | WO 2012/078688 |
| Date | 2012-06-14 |
| (30) | Number | Date | Country code |
| 420291 P | 2010-12-06 | US | |
| 201161446990 P | 2011-02-25 | US |
| (72) |
SMITH, Maria Leia, US
SUSSMAN, Django, US
ARTHUR, William, US
NESTEROVA, Albina, US
|
| (73) |
Seagen Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuoti antikūnai prieš Liv-1 ir jų panaudojimas vėžio gydymui |
| HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER |
| Payment date | Validity (years) | Amount | |
| 2024-11-12 | 14 | 289.00 EUR |
| 2025-12-06 |